These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19178874)

  • 21. Pharmacokinetics of intravenous and oral bolus doses of L-carnitine in healthy subjects.
    Harper P; Elwin CE; Cederblad G
    Eur J Clin Pharmacol; 1988; 35(5):555-62. PubMed ID: 3234464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Free and total carnitine concentrations in pig plasma after oral ingestion of various L-carnitine compounds.
    Eder K; Felgner J; Becker K; Kluge H
    Int J Vitam Nutr Res; 2005 Jan; 75(1):3-9. PubMed ID: 15830915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carnitines increase plasma levels of adenosine and ATP in humans.
    Capecchi PL; Laghi Pasini F; Quartarolo E; Di Perri T
    Vasc Med; 1997; 2(2):77-81. PubMed ID: 9546959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma and urine pharmacokinetics of free and of short-chain carnitine after administration of carnitine in man.
    Segre G; Bianchi E; Corsi M; D'Iddio S; Ghirardi O; Maccari F
    Arzneimittelforschung; 1988 Dec; 38(12):1830-4. PubMed ID: 3245856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of bolus intravenous and oral doses of L-carnitine in healthy subjects.
    Harper P; Elwin CE; Cederblad G
    Eur J Clin Pharmacol; 1988; 35(1):69-75. PubMed ID: 3220097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of l-carnitine chloride and its acetyl derivative on the electrophysiological derangement induced by palmityl-l-carnitine in isolated canine ventricular muscle.
    Matsui K; Nakazawa M; Takeda K; Imai S
    Jpn J Pharmacol; 1985 Oct; 39(2):263-70. PubMed ID: 4087570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of propionyl-L-carnitine on mechanical function of isolated rabbit heart.
    Ferrari R; Pasini E; Condorelli E; Boraso A; Lisciani R; Marzo A; Visiou O
    Cardiovasc Drugs Ther; 1991 Feb; 5 Suppl 1():17-23. PubMed ID: 2031870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The comparative pharmacokinetics of modified-release and immediate-release paracetamol in a simulated overdose model.
    Chiew A; Day P; Salonikas C; Naidoo D; Graudins A; Thomas R
    Emerg Med Australas; 2010 Dec; 22(6):548-55. PubMed ID: 21143403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanistic perspectives on differential mitochondrial-based neuroprotective effects of several carnitine forms in Alzheimer's disease in vitro model.
    Mota SI; Pita I; Águas R; Tagorti S; Virmani A; Pereira FC; Rego AC
    Arch Toxicol; 2021 Aug; 95(8):2769-2784. PubMed ID: 34164711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A study on the pharmacokinetics of chlorzoxazone in healthy Thai volunteers.
    Prompila N; Wittayalertpanya S; Komolmit P
    J Med Assoc Thai; 2007 Jan; 90(1):160-6. PubMed ID: 17621748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of acetyl- and proprionyl-L-carnitine on peripheral nerve function and vascular supply in experimental diabetes.
    Cotter MA; Cameron NE; Keegan A; Dines KC
    Metabolism; 1995 Sep; 44(9):1209-14. PubMed ID: 7666797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of oral acetyl-L-carnitine in renal impairment.
    Kelly JG; Hunt S; Doyle GD; Laher MS; Carmody M; Marzo A; Arrigoni Martelli E
    Eur J Clin Pharmacol; 1990; 38(3):309-12. PubMed ID: 2340852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of carnitine and its derivatives on gastric acid secretion in rats.
    Valoti M; Benocci A; Marazova K; Mantovani P
    Pharmacol Res; 1996; 34(5-6):219-24. PubMed ID: 9076846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carnitine derivatives: clinical usefulness.
    Malaguarnera M
    Curr Opin Gastroenterol; 2012 Mar; 28(2):166-76. PubMed ID: 22333562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomised clinical trial: the efficacy and safety of propionyl-L-carnitine therapy in patients with ulcerative colitis receiving stable oral treatment.
    Mikhailova TL; Sishkova E; Poniewierka E; Zhidkov KP; Bakulin IG; Kupcinskas L; Lesniakowski K; Grinevich VB; Malecka-Panas E; Ardizzone S; D'Arienzo A; Valpiani D; Koch M; Denapiene G; Vago G; Fociani P; Zerbi P; Ceracchi M; Camerini R; Gasbarrini G
    Aliment Pharmacol Ther; 2011 Nov; 34(9):1088-97. PubMed ID: 21929562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. L-carnitine and carnitine ester transport in the rat small intestine.
    Marciani P; Lindi C; Marzo A; Arrigoni Martelli E; Cardace G; Esposito G
    Pharmacol Res; 1991 Feb; 23(2):157-62. PubMed ID: 2062791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of craniotomy on oxidative stress and its effect on plasma L-carnitine levels.
    Li HT; Zhao ZH; Ding HY; Wang LX; Cao Y
    Can J Physiol Pharmacol; 2014 Nov; 92(11):913-6. PubMed ID: 25310338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism.
    Rebouche CJ
    Ann N Y Acad Sci; 2004 Nov; 1033():30-41. PubMed ID: 15591001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Propionyl-L-carnitine dilates human subcutaneous arteries through an endothelium-dependent mechanism.
    Cipolla MJ; Nicoloff A; Rebello T; Amato A; Porter JM
    J Vasc Surg; 1999 Jun; 29(6):1097-103. PubMed ID: 10359944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.